journal article·2014-01-22

Nanogold/Polyaniline/Penicillin G Nanoconjugates: A Novel Nanomedicine

Vasim Ahmed, Manoj Kumar, Jitendra Kumar, Manu Bhambi Chauhan, Nar Singh Chauhan

Publisher page

Abstract

Abstract A novel strategy was developed for one-step synthesis of PANI/gold nanoconjugates to develop new resistant penicillin G molecules. Spherical monodispersed PANI/gold colloids were prepared by a photochemical reaction between aqueous gold chloride solution and acidic polyaniline solution. Functionalized PANI/gold colloids were then grafted to the C3 carboxyl group of the β lactam ring of penicillin in the presence of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDAC) with a conjugation yield of 175 µg mg−1. These novel gold penicillin G nanoconjugates showed a very good growth inhibition against β lactam resistant Staphylococcus aureus (gram positive). This work thus describes a novel strategy for one step synthesis of PANI/gold colloids to develop resistant antibiotic nanoconjugates as novel bactericidal materials. Keywords: Antibiotic resistanceβ-lactamasegold nanoparticlesnanoconjugates Acknowledgment DBT-INDIA is duly acknowledged for the financial support under the DBT BioCARe scheme for carrying out the experiments.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery · SARS-CoV-2 detection and testing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. 10.1097/01.qco.0000393483.10270.ff10.1097/01.qco.0000393483.10270.ff ↗
2. 10.1186/2047-783X-15-12-57110.1186/2047-783X-15-12-571 ↗
3. 10.1016/j.mib.2010.09.00610.1016/j.mib.2010.09.006 ↗
4. 10.1098/rstb.1980.003810.1098/rstb.1980.0038 ↗
5. Fircanis S. · Med. Health Rhode Island · 2010 · 93 · 161
6. Neu H. C. · Am. J. Med. · 1985 · 79 · 2
7. 10.1021/bc00024a00410.1021/bc00024a004 ↗
8. Frezza M. · Int. J. Mol. Med. · 2008 · 21 · 689
9. 10.3181/0904-MR-13410.3181/0904-MR-134 ↗
10. 10.1016/j.tibtech.2010.07.00610.1016/j.tibtech.2010.07.006 ↗
11. 10.1016/j.pdpdt.2010.12.00110.1016/j.pdpdt.2010.12.001 ↗
12. 10.1166/jbn.2010.113510.1166/jbn.2010.1135 ↗
13. 10.1016/j.ejmech.2011.02.04810.1016/j.ejmech.2011.02.048 ↗
14. 10.1016/j.addr.2010.07.00910.1016/j.addr.2010.07.009 ↗
15. 10.1039/b821763g10.1039/b821763g ↗
16. 10.2116/analsci.26.121910.2116/analsci.26.1219 ↗
17. 10.1039/c000682n10.1039/c000682n ↗
18. 10.1016/j.molmed.2010.09.00410.1016/j.molmed.2010.09.004 ↗
19. 10.1016/j.micron.2010.09.00810.1016/j.micron.2010.09.008 ↗
20. 10.1002/anie.20090435910.1002/anie.200904359 ↗
21. 10.1166/jnn.2007.64310.1166/jnn.2007.643 ↗
22. 10.1016/j.cis.2004.07.00910.1016/j.cis.2004.07.009 ↗
23. 10.1021/ar800080n10.1021/ar800080n ↗
24. 10.1080/00914037.2010.48321710.1080/00914037.2010.483217 ↗
25. 10.1088/0957-4484/17/14/03710.1088/0957-4484/17/14/037 ↗
26. 10.1039/c0cc01990a10.1039/c0cc01990a ↗
27. Dey S. · Int. J. Pharma. Biosci. · 2010 · 1 · 35
28. 10.1016/j.bmcl.2003.10.06910.1016/j.bmcl.2003.10.069 ↗